Its role is to advise in the selection of clinical cohorts for the NRBC project, to develop and conduct clinical trials and to participate in ongoing project evaluation.

The Clinical Advisory Committee includes clinicians with a direct role in breast cancer management from the Sydney, Melbourne, Brisbane, Adelaide and Perth project sites, who are Associate Investigators within the project. The translational aspects of the project will be guided by Professor Richard Kefford, Associate Investigator, Westmead Millenium Institute

Dr Rosemary Balleine, Westmead Hospital, Translational Oncology
Dr Andrew Redfern, Royal Perth Hospital, Oncology
Dr Ben Wood, PathWest, Pathology
Mr Stewart Hart, Monash Medical Centre, Monash Cancer Services
Dr Stephen N. Birrell, Flinders Medical Centre, Breast Cancer Services
Dr Gary Leong, Mater Children’s Hospital, Paediatric Endocrinology

Its role is to advise on strategic directions, synergism and funding possibilities, and provision of independent oversight. The International Advisory Group comprises internationally renowned scientists and clinicians and it will be guided by Professor John Funder, Chief Investigator, Prince Henry’s Institute for Medical Research.

Nuclear receptor biology expertise: Bert O’Malley, Baylor College, USA
Clinical breast cancer expertise - Mitch Dowsett, ICR London, UK
Clinical breast cancer expertise - David Huntsman, University of British Columbia, Canada
Epidemiology of hormones and breast cancer expertise - Malcolm Pike, USC Norris Comprehensive Cancer Center, USA
Integrative molecular biology expertise - Chris Haiman, University of Southern California, USA.